Company news
Karyopharm Therapeutics Inc. news in 2025
Karyopharm Therapeutics Inc.'s news releases, calls and decks from 2025, newest first.
Karyopharm to Participate in Baird's Biotech Discovery Series
December 8, 2025
Karyopharm to Participate at the Piper Sandler 37th Annual Healthcare Conference
December 1, 2025
Karyopharm Reports Third Quarter 2025 Financial Results and Highlights Recent Company Progress
November 3, 2025
Karyopharm to Report Third Quarter 2025 Financial Results on November 3, 2025
October 27, 2025
Karyopharm Announces Strategic Financing Transactions to Support Growth; Extends Cash Runway Into Second Quarter of 2026, Beyond Expected Top-Line Readout of Phase 3 SENTRY Trial in Myelofibrosis
October 8, 2025
Karyopharm Announces Completion of Enrollment in the Phase 3 SENTRY Trial in Myelofibrosis
September 10, 2025
Karyopharm Reports Second Quarter 2025 Financial Results and Highlights Recent Company Progress
August 11, 2025
Karyopharm to Report Second Quarter 2025 Financial Results on August 11, 2025
August 5, 2025
Karyopharm to Present at the Jefferies Global Healthcare Conference
June 3, 2025
Karyopharm to Participate at the 2025 RBC Capital Markets Global Healthcare Conference
May 19, 2025
Karyopharm Announces Poster Presentation on Selinexor in Myelofibrosis at the 2025 European Hematology Association Annual Meeting
May 14, 2025
Karyopharm Reports First Quarter 2025 Financial Results and Announces New Data in Myelofibrosis that Further Suggests Selinexor May Lead to Meaningful Spleen Volume Reduction, Symptom Improvement, Hemoglobin Stabilization and Disease Modification
May 12, 2025
Karyopharm to Report First Quarter 2025 Financial Results on May 12, 2025
May 8, 2025
Karyopharm Announces 1-for-15 Reverse Stock Split
February 24, 2025
Karyopharm Reports Fourth Quarter and Full Year 2024 Financial Results, Announces Update to Phase 3 XPORT-EC-042 Trial and Highlights Recent Company Progress
February 19, 2025
Karyopharm to Report Fourth Quarter and Full Year 2024 Financial Results on February 19, 2025
February 11, 2025
Karyopharm Announces Preliminary Unaudited 2024 Revenue and 2025 Objectives
January 12, 2025
Karyopharm Announces the Appointment of Lori Macomber as Chief Financial Officer
January 1, 2025
Calls in 2025
- Karyopharm Therapeutics (NASDAQ:KPTI) Q3 2025 Earnings Call
Nov 3, 2025
Transcript - Karyopharm Therapeutics (NASDAQ:KPTI) Q2 2025 Earnings Call
Aug 11, 2025
Transcript - Karyopharm Therapeutics (NASDAQ:KPTI) Q1 2025 Earnings Call
May 12, 2025
Transcript - Karyopharm Therapeutics (NASDAQ:KPTI) Q4 2024 Earnings Call
Feb 19, 2025
Transcript
Decks in 2025
- Q3 2025 Earnings Presentation
Earnings · 31 slides · Nov 3, 2025
- Q2 2025 Earnings Presentation
Earnings · 34 slides · Aug 11, 2025
- Investor Presentation (July 2025)
Investor deck · 53 slides · Jul 11, 2025
- Q1 2025 Earnings Presentation
Earnings · 41 slides · May 12, 2025
- FY2024 Earnings Presentation
Earnings · 50 slides · Feb 19, 2025
- Society of Gynecologic Oncology (SGO) Annual Meeting on Women's Cancer 2025
Conference · 16 slides · 2025
- ESGO 2025
Conference · 14 slides · 2025